Demant AS (DEMANT):企業の財務・戦略的SWOT分析

◆英語タイトル:Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1159
◆発行会社(調査会社):GlobalData
◆発行日:2020年3月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Demant AS (DEMANT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Demant A/S (Demant), formerly William Demant Holding A/S is a provider of hearing healthcare solutions. The company develops, manufactures and distributes products designed to aid people with hearing loss. Its product portfolio includes hearing aids and fitting systems, hearing implants, audiometers, tympanometers, assistive listening devices, wireless sound systems, sound field systems and sound systems for larger premises. The company markets its products through its own retail chain, direct sales force, e-commerce channels and third-party distributors. The company and its subsidiaries operate in Europe, North America, Oceania and Asia-Pacific. Demant is headquartered in Smorum, Denmark.

Demant AS Key Recent Developments

Feb 04,2020: Demant : Annual Report 2019
Nov 18,2019: Demant : Interim management statement covering the period year-to-date
Sep 26,2019: Demant: Estimated financial impact of IT incident reflected in outlook
Aug 14,2019: Demant announces Interim report 2019
May 07,2019: Demant: Interim Management Statement covering the period year-to-date

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Demant A/S – Key Facts
Demant A/S – Key Employees
Demant A/S – Key Employee Biographies
Demant A/S – Major Products and Services
Demant A/S – History
Demant A/S – Company Statement
Demant A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Demant A/S – Business Description
Business Segment: Diagnostic Instruments
Overview
Performance
Business Segment: Hearing Devices
Overview
Performance
Business Segment: Hearing Implants
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Denmark
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other countries
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Pacific
Performance
Demant A/S – Corporate Strategy
Demant A/S – SWOT Analysis
SWOT Analysis – Overview
Demant A/S – Strengths
Demant A/S – Weaknesses
Demant A/S – Opportunities
Demant A/S – Threats
Demant A/S – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Demant A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Demant A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Demant A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2020: Demant : Annual Report 2019
Nov 18, 2019: Demant : Interim management statement covering the period year-to-date
Sep 26, 2019: Demant: Estimated financial impact of IT incident reflected in outlook
Aug 14, 2019: Demant announces Interim report 2019
May 07, 2019: Demant: Interim Management Statement covering the period year-to-date
Feb 19, 2019: William Demant Holding: Annual report 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Demant A/S, Key Facts
Demant A/S, Key Employees
Demant A/S, Key Employee Biographies
Demant A/S, Major Products and Services
Demant A/S, History
Demant A/S, Subsidiaries
Demant A/S, Key Competitors
Demant A/S, Ratios based on current share price
Demant A/S, Annual Ratios
Demant A/S, Annual Ratios (Cont...1)
Demant A/S, Annual Ratios (Cont...2)
Demant A/S, Interim Ratios
Demant A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Demant A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Demant A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Demant A/S, Performance Chart (2015 - 2019)
Demant A/S, Ratio Charts
Demant A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Demant A/S, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Demant AS (DEMANT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Credit Saison Co., Ltd.:企業のM&A・事業提携・投資動向
    Credit Saison Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Credit Saison Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) operates as a clinical-stage biopharmaceutical company. It carries out research, develop and commercialize gene editing technology. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target a …
  • Allied Hotel Properties Inc:企業の戦略・SWOT・財務情報
    Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Zoologischer Garten Berlin AG:企業の戦略・SWOT・財務情報
    Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report Summary Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Showa Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ICF International, Inc.:戦略・SWOT・企業財務分析
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Varta Microbattery GmbH:企業の戦略的SWOT分析
    Varta Microbattery GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Engie SA (ENGI)-エネルギー分野:企業M&A・提携分析
    Summary Engie S.A. (Engie), formerly GDF Suez S.A., is an electric utility, which generates and distributes electricity and natural gas. It generates electricity using various sources including hydro, wind, solar, biomass, geothermal, nuclear, coal and fuel oil. The company supplies, distributes, tr …
  • DiamondRock Hospitality Co:戦略・SWOT・企業財務分析
    DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report Summary DiamondRock Hospitality Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Insmed Inc (INSM)-医療機器分野:企業M&A・提携分析
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline includes …
  • Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Schindler Holding Ltd.:戦略・SWOT・企業財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TRACON Pharmaceuticals Inc (TCON):製薬・医療:M&Aディール及び事業提携情報
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • Blackbird Plc (BIRD):企業の財務・戦略的SWOT分析
    Summary Blackbird plc (Blackbird), formerly Forbidden Technologies plc, is a technology company that develops and commercializes cloud-based video technology. The company offers products such as FORscene- cloud-based post-production platform, captevate- online video editor and eva-video social netwo …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It also provides discovery chemistry, discovery biology, large molecule development, safety assess …
  • TC Pipelines LP (TCP):石油・ガス:M&Aディール及び事業提携情報
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • PTC Inc (PTC):企業の財務・戦略的SWOT分析
    PTC Inc (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Strabag SE:企業の戦略・SWOT・財務情報
    Strabag SE - Strategy, SWOT and Corporate Finance Report Summary Strabag SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AbbVie Inc (ABBV)-医療機器分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆